Non, l’Afrique n’est pas, ni de près ni de loin, la cible privilégiée des essais cliniques

10 April, 2020

Merci de diffuser ce texte extrêmement importantMylene botbol baumSent from my smartphone.

-------- Original message --------From: "Charles.Wiysonge" <Charles.Wiysonge@mrc.ac.za> Date: 10/04/2020 08:20 (GMT+01:00) To: HIFA-Fr <HIFA-Fr@dgroups.org> Subject: [hifa-fr] Non, l’Afrique n’est pas, ni de près ni de loin, la cible privilégiée des essais cliniques

Le chercheur Fred Eboko revient, dans une tribune au « Monde », sur la polémique déclenchée par deux scientifiques français proposant de tester sur le continent un vaccin contre le coronavirus.

https://www.lemonde.fr/afrique/article/2020/04/08/non-l-afrique-n-est-pa...

 

 

Professor Charles Shey Wiysonge

MD, MPhil, PhD, MASSAf

Director: Cochrane South Africa, South African Medical Research Council

Extraordinary Professor: Department of Global Health, Stellenbosch University

Honorary Professor: School of Public Health and Family Medicine, University of Cape Town

Researchgate:

https://www.researchgate.net/profile/Charles_Wiysonge

Twitter: @CharlesShey

 

 

Charles Wiysonge

Director

: South African Cochrane Centre

South African Medical Research Council

Tel: +27 21 9380804

| Cell:

Francie van Zijl Drive, Parow Valley

| Cape Town

| Western Cape

www.samrc.ac.za

Disclaimer - The information contained in this communication from the sender is confidential. It is intended solely for use by the

recipient and others authorized to receive it. If you are not the recipient, you are hereby notified that any disclosure, copying,

distribution or taking action in relation of the contents of this information is strictly prohibited and may be unlawful. This email

has been automatically archived by Mimecast SA (Pty) Ltd This e-mail and its contents are subject to the South African Medical Research

Council e-mail legal notice available at http://www.samrc.ac.za/about/EmailLegalNotice.htm.

You are receiving this message because you are a member of the community HIFA-Fr.

View this contribution on the web site

A reply to this message will be sent to all members of HIFA-Fr.

Reply to sender

| Unsubscribe